What is the Knee Osteoarthritis Treatment Gap?

Most people think of knee osteoarthritis (OA) treatment as a straight line: try conservative care, and if it stops working, have a knee replacement. In reality, there is a significant space between those two endpoints, and millions of Americans are stuck in it.

The knee osteoarthritis treatment gap is a real and documented problem. It refers to the period when a patient’s pain has exceeded what conservative care can manage, yet they are not yet an appropriate candidate for major joint replacement. Researchers formally identified and named this gap in peer-reviewed literature, estimating that approximately 3.6 million Americans live in it at any given time, a number projected to grow as OA diagnoses continue rising in younger adults.¹

What makes the gap particularly difficult is its duration. Nearly 20% of people with knee OA live in this space for an average of close to 20 years.² That is two decades of pain that is too significant for over-the-counter medications to address, yet not severe enough, or not appropriately timed, for a full joint replacement.

The gap is not a personal failure. It is a clinical reality with a name, a documented size, and a growing population that needs targeted options.

Is it Normal to Have Knee Pain under 50?

Yes, and it is more common than most people expect. Knee osteoarthritis has long been associated with older adults, but that picture has shifted. OA is increasingly being diagnosed in adults in their 30s, 40s, and early 50s, and the factors driving early-onset disease are well established.

If you have been dismissing knee pain as something you are “too young to worry about,” or if a provider has suggested you wait before exploring treatment, it is worth understanding what is actually happening in the joint and why earlier evaluation tends to preserve more options.

What causes knee osteoarthritis in younger adults?

Knee OA in younger patients is most often tied to specific, identifiable risk factors rather than the general wear of aging. The most common include:

• Prior joint injury — A history of ACL tear, meniscal tear, or significant knee trauma is one of the strongest predictors of early-onset OA. Cartilage damage from an injury can set off a degenerative process that accelerates over the following years.³
• Obesity — Every pound of body weight places approximately four pounds of pressure on the knee joint.⁴ Excess weight accelerates cartilage breakdown and promotes the chronic inflammation that drives OA pain.
• Genetics — OA can run in families. Inherited differences in cartilage composition or joint structure can make some people more susceptible at younger ages.
• Repetitive occupational or athletic stress — Jobs or sports that place repeated demand on the knee joint over years can accelerate the wear process beyond what age alone would produce.
• Post-traumatic arthritis — This form of OA develops directly from a joint injury, sometimes within a few years of the initial trauma, and is a leading cause of knee OA in adults under 50.

Understanding the four stages of knee osteoarthritis can help clarify where symptoms are coming from and what treatment approaches are appropriate at each level of progression.

Why younger patients often wait too long

Younger adults, particularly those who are active or athletic, tend to have a higher tolerance for pain and a stronger inclination to push through discomfort rather than seek evaluation. This delay is understandable, but the longer a patient waits, the fewer minimally invasive options remain available.

Research confirms that younger adults with knee OA face a harder situation than it might appear from the outside. Chronic knee pain during your busiest years, when family and work demands are highest, affects more than just your body. The psychosocial impact on career, caregiving, and daily independence is well documented.³

How the Knee Treatment Gap Looks Different at Every Age

The knee OA treatment gap is not a single experience. Where a patient sits in the gap, and what options remain available, depends significantly on their age, OA severity, and treatment history.

Note: Staging descriptors can be updated and advise discussing further with your physician to align with current clinical practice.

Why Younger Adults Seek Alternatives to Knee Replacement

Two things explain why younger patients feel this way about knee replacement, and neither comes down to fear alone.

First, patients in their 40s and 50s are frequently told by providers that they are “too young” for a knee replacement. This is not dismissive advice; it reflects a genuine clinical consideration. A knee implant has a functional lifespan of approximately 15 to 25 years. A patient who undergoes replacement at 48 may require a second, more complex revision surgery during their 60s or 70s, a prospect most patients and physicians prefer to avoid when other options remain.

Second, knee replacement does not guarantee satisfaction for every patient. Studies show that roughly 10 to 20% of patients are not fully satisfied with their pain and functional outcomes after total knee arthroplasty, and between 31 and 54% experience some residual symptoms after the procedure.⁵ For a patient who is not yet at end-stage OA, those figures matter for someone who still has options.

The problem with waiting it out

Choosing to wait is not a neutral decision. When knee pain limits activity, patients tend to move less. Reduced movement weakens the muscles that support the joint, which shifts more load onto already-damaged cartilage. Reduced activity also contributes to weight gain, which increases joint pressure and promotes inflammation. Over time, watchful waiting can push a patient deeper into the gap rather than buying them more time.

When conservative treatments stop working

Conservative care has an important role early in OA management, and most patients move through several approaches before reaching the gap. The typical arc includes OTC pain relievers and anti-inflammatories, structured physical therapy, corticosteroid injections for acute flares, and hyaluronic acid injections for joint lubrication. Each of these approaches can provide meaningful relief at the right stage of OA. Each also has a ceiling.

As OA progresses, inflammation becomes harder to manage, and treatments that once helped for months may only last weeks. Physical therapy may maintain some function but no longer reduce pain significantly. When a patient has moved through most or all of these options without lasting improvement, they have arrived in the gap.⁵

For many patients, the question is not whether to keep waiting, but what comes next. Reviewing how GAE compares to knee replacement in terms of procedure, recovery, and outcomes can help clarify what that next step looks like.

Filling the gap: What is Genicular Artery Embolization (GAE)?

Genicular Artery Embolization is a minimally invasive, outpatient procedure performed by a board-certified interventional radiologist. It has become the primary minimally invasive option for patients in the treatment gap: those with moderate to severe knee OA pain who have not responded adequately to conservative care and who are not yet appropriate candidates for, or do not desire, joint replacement.

GAE does not involve surgery, general anesthesia, or a hospital stay. Most patients return to normal daily activities within one to three days.

How GAE targets knee inflammation at its source

As cartilage breaks down, the body responds by growing abnormal new blood vessels into the lining of the knee joint, a process called neovascularization. These vessels are not beneficial. They carry inflammatory cells into the joint, intensifying pain signals and sustaining the chronic inflammation that makes knee OA so persistent.⁶

GAE addresses this process directly. During the procedure, an interventional radiologist guides a thin catheter, typically inserted through a small access point at the wrist or upper thigh, to the genicular arteries supplying the inflamed knee tissue. Microscopic particles are then delivered to reduce abnormal blood flow in those vessels. By interrupting the inflammatory blood supply, GAE reduces pain and swelling without cutting into or altering the joint structure.

Because the anatomy of the knee is preserved entirely, patients who have GAE remain eligible for other treatment options, including knee replacement, if their condition changes in the future.

Who may be a candidate for GAE?

GAE may be appropriate for adults who experience chronic knee pain from osteoarthritis and have not found adequate relief through conservative treatments such as medications, physical therapy, or injections. Patients who receive only limited relief from corticosteroid or hyaluronic acid injections, or those who prefer a long-term non-surgical option, are among those who may benefit.

GAE is not appropriate for every patient with knee OA, and a specialist evaluation is required to determine individual candidacy. To review the full candidacy criteria and find out if you are a candidate for GAE, a consultation with a USA Pain Center specialist is the appropriate next step.

For a broader look at what is available, exploring GAE as a knee pain treatment option at USA Pain Center can help patients understand the full landscape before scheduling.

What the Research Shows About GAE

The clinical evidence supporting GAE for knee OA has grown substantially over the past several years, with multiple prospective trials and long-term follow-up studies now published in peer-reviewed interventional radiology and orthopedic journals.

A prospective investigational device exemption trial conducted at UCLA followed 40 patients with moderate to severe knee OA through 24 months after GAE. At the two-year mark, 47.4% of patients achieved a 50% or greater reduction in their WOMAC pain scores. Among patients who demonstrated initial clinical success at 12 months, 72% maintained that improvement at 24 months.⁷

The GENESIS trial, a separate prospective study using permanent microspheres, reported sustained efficacy at two years in patients with mild to moderate knee OA, with no serious adverse events recorded during that follow-up period.⁸

A 2025 study from UCLA analyzing 236 patients who underwent GAE found durable clinical improvement at one year, with the strongest results in younger patients and those with earlier-stage OA. The authors concluded that early intervention with GAE may be appropriate for patients who are not candidates for, or do not desire, total knee arthroplasty.⁹

Together, these studies suggest GAE can make a real difference for patients in the treatment gap, particularly those who seek evaluation before their condition reaches its most advanced stages.

For additional context, read about effective solutions for active adults with knee pain.

Getting Evaluated: what to expect at USA Pain Center

Knee osteoarthritis care at USA Pain Center begins with a comprehensive evaluation that reviews your symptom history, prior treatments, and imaging to build a complete picture of where you are in your OA progression. A board-certified interventional radiologist uses that information to determine whether GAE is appropriate for your specific condition.

There is no single right moment to seek an evaluation, but the research is consistent on one point: patients evaluated while their OA is still in the moderate range typically have more minimally invasive options available than those who wait until symptoms are severe. If you have been living with knee pain that no longer responds to the treatments you have tried, or if you have been told to wait without being offered an alternative, an evaluation can clarify what is actually available to you now.